1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Infliximab
Trade Name:
Avsola
Manufacturer/Distributor:
Amgen Canada Inc.
Classification:
Biological response modifier
ATC Class:
L04AB02
Status:
active
Notice of Compliance (yyyy/mm/dd):
2020/03/12
Date Marketed in Canada (yyyy/mm/dd):
2020/06/01
Presentation:
Powder for solution 100 mg. DIN 02496933
Comments:
For treatment of rheumatoid arthritis, anklyosing spondylitis, Crohn's disease, ulcerative colitis, psoriatic arthritis and plaque psoriasis.
Back to:
Drug Product Listings 
